Tag: Genomic
Genomic Vision has been placed in receivership
By Olivier Cheilan Published on 11/17/2023 at 6:20 p.m. Photo credit © Euronext (Boursier.com) — After declaring itself…
Genomic Vision in receivership – 11/17/2023 at 6:26 p.m.
(AOF) – Genomic Vision announces that at its request reported on November 3, the Nanterre Commercial Court decided on November 15, 2023 the opening of a judicial recovery procedure. The…
Genomic Vision in receivership
(AOF) – Genomic Vision announces that at its request reported on November 3, the Nanterre Commercial Court decided on November 15, 2023 the opening of a judicial recovery procedure. The…
Genomic Vision: cessation of payment, recovery in sight – 06/11/2023 at 10:15
(CercleFinance.com) – Genomic Vision announced on Friday that it had declared cessation of payments to the Nanterre Commercial Court, to which it had also requested the opening of a judicial…
Genomic Vision requests the opening of legal recovery proceedings
(AOF) – Genomic Vision announces that it has today filed a declaration of cessation of payments with the Nanterre Commercial Court, and requested the opening of a judicial recovery procedure.…
Genomic Vision requests the opening of a judicial recovery procedure – 03/11/2023 at 6:00 p.m.
Bagneux (France) – Genomic Vision (FR0011799907 – GV, the “Company”), a biotechnology company listed on Euronext developing products and services for the precise characterization of DNA sequences, announces that it…
Genomic Vision requests the opening of a judicial recovery procedure – 03/11/2023 at 6:21 p.m.
(AOF) – Genomic Vision announces that it has today filed a declaration of cessation of payments with the Nanterre Commercial Court, and requested the opening of a judicial recovery procedure.…
Genomic Vision looking for financing solutions – 09/29/2023 at 6:25 p.m.
(AOF) – Genomic Vision had cash of 14,000 euros as of June 30, 2023, compared to 760,000 euros as of June 30, 2022, and the financial resources available in the…
Genomic Vision looking for financing solutions
(AOF) – Genomic Vision had cash of 14,000 euros as of June 30, 2023, compared to 760,000 euros as of June 30, 2022, and the financial resources available in the…
Genomic Vision: The net result as of June 30 stands at -6.4 ME
(Boursier.com) — The turnover for the 1st half of 2023 amounts to 593 KE, an increase of 16% compared to the 1st half of 2022.These two semesters each include the…
Genomic Vision launches HexaCard, a new service for the characterization of transformed cell lines – 07/18/2023 at 07:00
• HexaCard is an innovative service to improve quality control in cell characterization for bioproduction, cell and gene therapy applications • HexaCard offers a highly accurate analytical method for characterizing…
Genomic Vision soars at the announcement of its share buyback program – 06/29/2023 at 10:20 am
(AOF) – Genomic Vision gained more than 37% to 0.016 euro after publishing a description of its share buyback program. Biotech announces that the maximum share of the capital whose…